36 reports

Tissue inhibitor of metalloproteinase ## (TIMP-##) showed statistically significant reduction; mean change of TIMP-##, -##. ## IU, P=##. ##.

  • Digestive System Disorder
  • Hospital
  • Immunotherapy
  • Stroke
  • TaiwanJ Pharmaceuticals Co., Ltd.

ACTEMRA IS INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO ONE OR MORE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS VIA INTRAVENOUS AND SUBCUTANEOUS ROUTE.

  • Digestive System Disorder
  • Endocrine Disease
  • United States
  • Product Initiative
  • Alnylam Pharmaceuticals, Inc.

In December 2002, Amgen initiated another Phase II double-blind, placebo controlled, randomized, parallel-group clinical trial with multiple dose treatment of anti-il ## human monoclonal antibody (AMG ##) in patients with active rheumatoid arthritis who have previously failed one or more d

  • Digestive System Disorder
  • Therapy
  • United States
  • Company
  • Product Initiative

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Endocrine Disease
  • World
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.

ACTEMRA IS INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO ONE OR MORE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS VIA INTRAVENOUS AND SUBCUTANEOUS ROUTE.

  • Digestive System Disorder
  • Endocrine Disease
  • Hospital
  • Therapy
  • Alnylam Pharmaceuticals, Inc.

Additionally, one in eight men and one in eleven women are likely to die from this disease.

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • World
  • Market Size

The RA-BUILD study included patients with moderately-to-severely active rheumatoid arthritis who had an inadequate response to, or were intolerant of, at least one conventional diseasemodifying antirheumatic drug (cDMARD).

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Type 2 Diabetes
  • United States
  • GASTRITIS - PIPELINE BY BCWORLD PHARM CO LTD, H1 2018

IBS is one of the most common gastrointestinal disorders.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Company Operations
  • RedHill Biopharma Ltd.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • United States
  • Product Initiative

The study will be conducted with patients with active arthritis who are referred to the special department for treatment with antirheumatic drugs that treat diseases where first-line treatment is methotrexate.

  • Digestive System Disorder
  • Endocrine Disease
  • China
  • World
  • Product Initiative

The RA-BUILD study included patients with moderately-to-severely active rheumatoid arthritis who had an inadequate response to, or were intolerant of, at least one conventional diseasemodifying antirheumatic drug (cDMARD).

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • United States
  • Product Initiative
  • SUBJECTS WITH CROHN'S DISEASE. THE TRIAL WAS REGISTERED WITH THE U.S. NATIONAL INSTITUTES OF HEALTH.

ABBVIE REGISTERED THE FOLLOWING PHASE III TRIALS WITH THE TITLES RANDOMIZED, DOUBLE-BLIND, SELECT- PSA ## STUDY COMPARING ABT-## TO PLACEBO AND TO ADALIMUMAB IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS WHO HAVE A HISTORY OF INADEQUATE RESPONSE TO AT LEAST ONE NON-BIOLOGIC DISEASE M

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • United States
  • Company

Patients were randomized to receive AM- ## ##. ## mg/ mL, ##. ## mg/ mL or placebo in a ##:##:## ratio.

  • Digestive System Disorder
  • Endocrine Disease
  • Monoclonal Antibody
  • Stroke
  • United States

The RA-BUILD study included patients with moderately-to-severely active rheumatoid arthritis who had an inadequate response to, or were intolerant of, at least one conventional diseasemodifying antirheumatic drug (cDMARD).

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • United States
  • Product Initiative

One external remote patient monitoring device consists of one external module or transmitter.

  • Cardiovascular Disease
  • Clinical Trial
  • Stroke
  • United States
  • Pfizer Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Vitamin
  • World

It also provides gastrointestinal agents, anti-rheumatic, narcotics, vitamin B## supplements and vitamin C supplements, anti-spasmodic, and autonomic nervous systems, among others.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Molecular Diagnostics
  • Pathology
  • Therapy
  • Clinical Trial profile. 749 Trial Title
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Vitamin
  • World

One unit refers to one disposable insulin pen.

  • Digestive System Disorder
  • Endocrine Disease
  • Pharmaceutical
  • Stroke
  • Sanofi S.A.

In December 2002, Amgen initiated another Phase II double-blind, placebo controlled, randomized, parallel-group clinical trial with multiple dose treatment of anti-il ## human monoclonal antibody (AMG ##) in patients with active rheumatoid arthritis who have previously failed one or more d

  • Digestive System Disorder
  • Pathology
  • Therapy
  • United States
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Digestive System Disorder
  • Drug Development
  • Endocrine Disease
  • Stroke
  • World
  • DYSLIPIDEMIA - PIPELINE BY BCWORLD PHARM CO LTD, H1 2019
  • DYSLIPIDEMIA - PIPELINE BY ASTRAZENECA PLC, H1 2019

It also provides gastrointestinal agents, antirheumatic, narcotics, vitamin B## supplements and vitamin C supplements, anti-spasmodic, and autonomic nervous systems, among others.

  • Chronic Disease
  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Amarin Corporation plc

The study will be a multiple dose, double-blind, placebo-controlled trial in patients with active RA who have previously failed one or more disease modifying anti-rheumatic drugs (DMARDs).

  • Digestive System Disorder
  • Medical Biotechnology
  • Stroke
  • World
  • Product Initiative

SEVENTY-ONE PERCENT OF ALL U. S.

  • Digestive System Disorder
  • Stroke
  • United States
  • Product Initiative
  • GlaxoSmithKline plc

The company provides cardiovascular, psychoneurotic, anti-cancer, antihistamine, antirheumatic and benign prostatic hyperplasia drugs.

  • Cardiovascular Disease
  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Esperion Therapeutics, Inc.

THE STUDY WILL BE A MULTIPLE DOSE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH ACTIVE RA WHO HAVE PREVIOUSLY FAILED ONE OR MORE DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS).

  • Digestive System Disorder
  • Medical Biotechnology
  • United States
  • World
  • Product Initiative
  • STROKE - PIPELINE BY SAVARA INC, H1 2018
  • STROKE - PIPELINE BY SHIN POONG PHARMCO LTD, H1 2018

The company provides cardiovascular, psychoneurotic, anti-cancer, antihistamine, antirheumatic and benign prostatic hyperplasia drugs.

  • Chronic Disease
  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Product Initiative

SAL-## acts as an inhibitor of very late antigen ## (VLA-## or integrin alpha ## beta ##).

  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • United States
  • Valeant Pharmaceuticals International, Inc.
  • Clinical Trial Profile Snapshots

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Endocrine Disease
  • Pharmaceutical
  • World

The study conducted in Japan consisted of randomized, double-blind, placebo-controlled Phase III clinical trials in patients with rheumatoid arthritis with disease-modifying anti-rheumatic drugs (DMARDs).

  • Cancer
  • Digestive System Disorder
  • Endocrine Disease
  • Stroke
  • Daiichi Sankyo Company